Neuroprotective Products Market to Receive Impetus from New Launches and Rising Incidence of Parkinson’s Disease

A new report from Transparency Market Research, titled ‘Neuroprotective Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,’ states that the growth of the global neuroprotective products market is expected to be propelled by factors such as the rising incidence of Parkinson’s disease, the introduction of new neuroprotective products, and the growing use of these medicines.

Get a Free Sample Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1976

Neuroprotective products are medicines used to preserve or protect the neuronal structure of the brain from any kind of injury or from degeneration. Neuroprotective products are primarily used as a treatment alternative for various central nervous system complications including stroke, spinal cord injury, neurodegenerative diseases, and traumatic brain injury. The prime objective of these medicines is to minimize the malfunction or dysfunction of neurons post a brain injury. Neuroprotective medicines also assist in retaining the integrity of the various functions of cells in the brain.

Leading players in the global neuroprotective products market offer various neuroprotective products. Some of the commonly available neuroprotective products in the global market are anti-excitotoxic agents, anti-inflammatory agents, metal ion chelators, neurotropic factors, ion channel modulators, gene therapy, apoptosis inhibitors, free radical trappers, and mitochondrial dysfunction regulators. The introduction of new neuroprotective products by leading players is expected to propel the global market for neuroprotective products in the years to come. The entry of new players is also expected to contribute towards the growth of the global neuroprotective products market in the next few years.

Neuroprotective products or medicines are used to treat various medical conditions such as Alzheimer’s disease, brain injury, ocular degeneration, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, amyotrophic lateral sclerosis, and others. One of the major factors expected to propel the global neuroprotective products market is the rising incidence of neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson’s disease, and Alzheimer’s disease. The increasing demand for improved medications, especially for brain injuries, is predicted to boost the global neuroprotective products market in the next few years. However, strict regulatory approvals and the high development costs are two of the factors expected to hamper the growth of the global neuroprotective products market in the next few years.

By geography, the global neuroprotective products market is divided into North America, Asia Pacific, Europe, and Rest of the World. Currently, the global neuroprotective products market is led by North America due to the rise in the neurodegenerative disorder cases. As of 2012, as per the report from Alzheimer’s Association (AA), nearly 5.4 million people in the U.S. suffer from Alzheimer’s disease. Furthermore, every year, around 60,000 people in the U.S. are diagnosed with Parkinson’s disease.

Some of the leading players in the global neuroprotective products market are BHR Pharma LLC, NeuroVive Pharmaceutical AB, Allon Therapeutics Inc., and Genervon Biopharmaceuticals LLC.

Full Research Report on Global Neuroprotective Products Market:
http://www.transparencymarketresearch.com/neuroprotective-products-market.html

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

90 State Street, Suite 700 Albany, NY 12207

This release was published on openPR.